Sonoma Pharmaceuticals Receives Brazilian Approvals to Market Multiple Hypochlorous Acid-Based Dermatology Products
October 31, 2017 07:45 ET
|
Sonoma Pharmaceuticals, Inc.
Brazilian Ministério da Saúde Approves Marketing of Sonoma Pharmaceuticals’ Products: Lasercyn™, Gramaderm®, Epicyn™ and Pediacyn™ Brazilian Dermatology Market Second Largest in the World Behind the...
Sonoma Pharmaceuticals Announces Commercialization of MicrocynAH® Animal Healthcare Products in Japan
September 14, 2017 04:05 ET
|
Sonoma Pharmaceuticals, Inc.
PETALUMA, Calif., Sept. 14, 2017 (GLOBE NEWSWIRE) -- Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA, warrants SNOAW), a specialty pharmaceutical company that develops and markets unique and effective...
Sonoma Pharmaceuticals Reports Financial Results for Fourth Quarter and Fiscal Year 2017
June 05, 2017 16:05 ET
|
Sonoma Pharmaceuticals, Inc.
Product revenue for fourth quarter up 60% and for fiscal year 2017 up 48%, compared to last year, driven by growth in U.S. dermatology salesCash position of $17.5 million; management believes the...
Eloquest Healthcare(r) Featured on TV's "Today in America" With Terry Bradshaw
July 24, 2013 12:06 ET
|
Eloquest Healthcare, Inc.
Ferndale, MI, July 24, 2013 (GLOBE NEWSWIRE) -- Eloquest Healthcare, Incorporated was recently featured on the
syndicated television program "Today in America" with Terry
Bradshaw. The broadcast...